The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Glucagon Like Peptide-1-Induced Glucose Metabolism in Differentiated Human Muscle Satellite Cells Is Attenuated by Hyperglycemia
Open accessAbstract
BACKGROUND: Glucagon like peptide-1 (GLP-1) stimulates insulin secretion from the pancreas but also has extra-pancreatic effects. GLP-1 may stimulate glucose uptake in cultured muscle cells but the mechanism is not clearly defined. Furthermore, while the pancreatic effects of GLP-1 are glucose-dependent, the glucose-dependency of its extra-pancreatic effects has not been examined. METHODS: Skeletal muscle satellite cells isolated from young (22.5 ± 0.97 yr), lean (BMI 22.5 ± 0.6 kg/m(2)), healthy males were differentiated in media containing either 22.5 mM (high) or 5 mM (normal) glucose for 7 days in the absence or presence of insulin and/or various GLP-1 concentrations. Myocellular effects of GLP-1, insulin and glucose were assessed by western-blot, glucose uptake and glycogen synthesis. RESULTS: We firstly show that the GLP-1 receptor protein is expressed in differentiated human muscle satellite cells (myocytes). Secondly, we show that in 5 mM glucose media, exposure of myocytes to GLP-1 results in a dose dependent increase in glucose uptake, GLUT4 amount and subsequently glycogen synthesis in a PI3K dependent manner, independent of the insulin signaling cascade. Importantly, we provide evidence that differentiation of human satellite cells in hyperglycemic (22.5 mM glucose) conditions increases GLUT1 expression, and renders the cells insulin resistant and interestingly GLP-1 resistant in terms of glucose uptake and glycogen synthesis. Hyperglycemic conditions did not affect the ability of insulin to phosphorylate downstream targets, PKB or GSK3. Interestingly we show that at 5 mM glucose, GLP-1 increases GLUT4 protein levels and that this effect is abolished by hyperglycemia. CONCLUSIONS: GLP-1 increases glucose uptake and glycogen synthesis into fully-differentiated human satellite cells in a PI3-K dependent mechanism potentially through increased GLUT4 protein levels. The latter occurs independently of the insulin signaling pathway. Attenuation of both GLP-1 and insulin-induced glucose metabolism by hyperglycemia is likely to occur downstream of PI3K.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




![Figure 5 Effect of GLP-1 treatment on glycogen synthesis in myocytes cultured in high or normal glucose media. Satellite cells were isolated from lean, healthy males (n = 6), and differentiated in either high glucose (22 mM, open bars) or normal glucose (5 mM, black bars) media for seven days. Myocytes were treated with either 100 nM insulin and/or 100 nM GLP-1 for 30 minutes before assessing glycogen synthesis (by measuring incorporation of [14C]-glucose in to glycogen). (A) Shows absolute rates of glycogen synthesis in the basal level (n = 6, in triplicate); (B) indicates fold changes from basal levels for each glucose condition. Significant changes from basal levels are indicated by * (P<0.05), and ** (P<0.001).](https://figures.cochat.ai/paper-figures/e3522dd307874d039d601f5d7319c0c2/glucagon-like-peptide-1-induced-glucose-metabolism-in-differentiated-human-figure-5.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The notable advantage for muscle preservation seems to be the use of glucagon-like peptide-1 (GLP-1) receptor agonists34,35 and dipeptidyl peptidase-4 inhibitors (DPP-4i),36–38 which not only minimally affects muscle mass loss but also stimulates muscle contraction and aid in muscle recovery.”
From Imaging of Sarcopenia in Type 2 Diabetes Mellitus (2024) · cites this paper as [34]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
Hidaka, H., Inagaki, M., Kawamoto, S., & Sasaki, Y. (1984) · Biochemistry · doi:10.1021/bi00316a032 · Cited by 2,687
Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes
DeFronzo, R. A., & Tripathy, D. (2009) · Diabetes Care · doi:10.2337/dc09-s302 · Cited by 2,102 · cited 1×
“Similarly, in hyperglycemic individuals skeletal muscle insulin sensitivity of glucose uptake is also poor [16].”
BackgroundA role for glucagon-like peptide-1 in the central regulation of feeding
Turton, M. D., O'Shea, D., Gunn, I., Beak, S. A., Edwards, C. M. B., Meeran, K., Choi, S. J., Taylor, G. M., Heath, M. M., Lambert, P. D., et al. (1996) · Nature · doi:10.1038/379069a0 · Cited by 1,950
MicroRNAs 103 and 107 regulate insulin sensitivity
Trajkovski, M., Hausser, J., Soutschek, J., Bhat, B., Akin, A., Zavolan, M., Heim, M. H., & Stoffel, M. (2011) · Nature · doi:10.1038/nature10112 · Cited by 1,000
Rates and tissue sites of non-insulin- and insulin-mediated glucose uptake in humans
Baron, A. D., Brechtel, G., Wallace, P., & Edelman, S. V. (1988) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1988.255.6.e769 · Cited by 642
Gutzwiller, J.-P., Drewe, J., Göke, B., Schmidt, H., Rohrer, B., Lareida, J., & Beglinger, C. (1999) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1999.276.5.r1541 · Cited by 521
The incretin system and its role in type 2 diabetes mellitus
HOLST, J., VILSBOLL, T., & DEACON, C. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.08.012 · Cited by 515
Xia, P., Inoguchi, T., Kern, T. S., Engerman, R. L., Oates, P. J., & King, G. L. (1994) · Diabetes · doi:10.2337/diab.43.9.1122 · Cited by 477
Buteau, J., Roduit, R., Susini, S., & Prentki, M. (1999) · Diabetologia · doi:10.1007/s001250051238 · Cited by 413 · cited 3×
“Furthermore, inhibition of PI3K led to suppressed DNA synthesis by GLP-1 in INS-1 cells [27].”
BackgroundDownregulation of GLP-1 and GIP Receptor Expression by Hyperglycemia
Xu, G., Kaneto, H., Laybutt, D. R., Duvivier-Kali, V. F., Trivedi, N., Suzuma, K., King, G. L., Weir, G. C., & Bonner-Weir, S. (2007) · Diabetes · doi:10.2337/db06-1033 · Cited by 377
Buteau, J., Foisy, S., Rhodes, C. J., Carpenter, L., Biden, T. J., & Prentki, M. (2001) · Diabetes · doi:10.2337/diabetes.50.10.2237 · Cited by 252
Bandyopadhyay, G., Standaert, M. L., Galloway, L., Moscat, J., & Farese, R. V. (1997) · Endocrinology · doi:10.1210/endo.138.11.5473 · Cited by 218
Shi, J., & Kandror, K. V. (2005) · Developmental Cell · doi:10.1016/j.devcel.2005.04.004 · Cited by 202
Alessi, D. R. (1997) · FEBS Letters · doi:10.1016/s0014-5793(96)01510-4 · Cited by 200
Chai, W., Dong, Z., Wang, N., Wang, W., Tao, L., Cao, W., & Liu, Z. (2012) · Diabetes · doi:10.2337/db11-1073 · Cited by 194
Esguerra, J. L. S., Bolmeson, C., Cilio, C. M., & Eliasson, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018613 · Cited by 190
Endocytosis, Recycling, and Regulated Exocytosis of Glucose Transporter 4
Foley, K. P., Boguslavsky, S., & Klip, A. (2011) · Biochemistry · doi:10.1021/bi2000356 · Cited by 179
Transcription factor FoxO1 mediates glucagon-like peptide-1 effects on pancreatic β-cell mass
Buteau, J., Spatz, M. L., & Accili, D. (2006) · Diabetes · doi:10.2337/db05-0825 · Cited by 178
Glucose transport in human skeletal muscle cells in culture. Stimulation by insulin and metformin.
Sarabia, V, Lam, L., Burdett, E., Leiter, L. A., & Klip, A. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116005 · Cited by 175
Tolessa, T., Gutniak, M., Holst, J. J., Efendic, S., & Hellström, P. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci942 · Cited by 139
GLP-1 action in L6 myotubes is via a receptor different from the pancreatic GLP-1 receptor
Yang, H. M., Egan, J. M., Wang, Y., Moyes, C. D., Roth, J., Montrose, M. H., & Montrose‐Rafizadeh, C. (1998) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1998.275.3.c675 · Cited by 136
Glucagon-like peptide-1 (GLP-1) and glucose metabolism in human myocytes
Luque, M. A., González, N., Marquez, L., Acitores, A., Redondo, A., Morales, M., Valverde, I., & Villanueva-Penacarrillo, M. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1730465 · Cited by 135
Ayala, J. E., Bracy, D. P., James, F. D., Julien, B. M., Wasserman, D. H., & Drucker, D. J. (2008) · Endocrinology · doi:10.1210/en.2008-0945 · Cited by 125
Green, C., Pedersen, M., Pedersen, B. K., & Schéele, C. (2011) · Diabetes · doi:10.2337/db11-0263 · Cited by 122
Self-citationGromada, J., Ding, W.-G., Barg, S., Renström, E., & Rorsman, P. (1997) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/s004240050431 · Cited by 110
Xia, P., Inoguchi, T., Kern, T. S., et al. (1994) · Diabetes · doi:10.2337/diabetes.43.9.1122 · Cited by 109
Kanzaki, M., Mora, S., Hwang, J., Saltiel, A. R., & Pessin, J. E. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200306152 · Cited by 105
Palmitate-induced Down-regulation of Sortilin and Impaired GLUT4 Trafficking in C2C12 Myotubes
Tsuchiya, Y., Hatakeyama, H., Emoto, N., Wagatsuma, F., Matsushita, S., & Kanzaki, M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.128520 · Cited by 91
Inagaki, M., Kawamoto, S., Naka, M., Sasaki, Y., & Hidaka, H. (1984) · The Japanese Journal of Pharmacology · doi:10.1016/s0021-5198(19)62347-4 · Cited by 90
Alcántara, A., Morales, M., Delgado, E., López-Delgado, M. I., Clemente, F., Luque, M., Malaisse, W. J., Valverde, I., & Villanueva-Peñacarrillo, M. (1997) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1997.9951 · Cited by 85
Effect of GLP-1 on glucose transport and its cell signalling in human myocytes
González, N., Acitores, A., Sancho, V., Valverde, I., & Villanueva-Peñacarrillo, M. L. (2005) · Regulatory Peptides · doi:10.1016/j.regpep.2004.10.002 · Cited by 85
Glucagonlike Peptide-1 (GLP-1) Participation in Ileal Brake Induced by Intraluminal Peptones in Rat
Giralt, M., & Vergara, P. (1999) · Digestive Diseases and Sciences · doi:10.1023/a:1026654417697 · Cited by 82
Wijesekara, N., Tung, A., Thong, F. S. L., & Klip, A. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00573.2005 · Cited by 81
GLP-1 amplifies insulin signaling by up-regulation of IRβ, IRS-1 and Glut4 in 3T3-L1 adipocytes
Gao, H., Wang, X., Zhang, Z., Yang, Y., Yang, J., Li, X., & Ning, G. (2007) · Endocrine · doi:10.1007/s12020-007-9011-4 · Cited by 77 · cited 1×
“In support of GLP-1 regulation of GLUT4 expression it has been reported that treatment of adipocytes with GLP-1 increases glucose uptake and protein expression of both GLUT4 and GLUT2 in total cell lysates [37].”
BackgroundGalante, P., Mosthaf, L., Kellerer, M., Berti, L., Tippmer, S., Bossenmaier, B., Fujiwara, T., Okuno, A., Horikoshi, H., & Ulrich Häring, H. (1995) · Diabetes · doi:10.2337/diab.44.6.646 · Cited by 77 · cited 1×
“A number of studies have shown that hyperglycemia increases glucose transport through the activation of diacylglycerol (DAG) sensitive PKCs (novel and conventional), particularly through PKCbII [31,32].”
BackgroundGlucagon-like peptide-1 binding to rat skeletal muscle
Delgado, E., Luque, M. A., Alcántara, A., Trapote, M. A., Clemente, F., Galera, C., Valverde, I., & Villanueva‐Peñacarrillo, M. L. (1995) · Peptides · doi:10.1016/0196-9781(94)00175-8 · Cited by 73
Standaert, M. L., Avignon, A., Yamada, K., Bandyopadhyay, G. K., & Farese, R. V. (1996) · Biochemical Journal · doi:10.1042/bj3131039 · Cited by 66
Chronic hyperglycemia reduces substrate oxidation and impairs metabolic switching of human myotubes
Aas, V., Hessvik, N. P., Wettergreen, M., Wensaas, A. J., Hallén, S., Thoresen, G. H., & Rustan, A. C. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.09.014 · Cited by 58
Cell signalling of glucagon-like peptide-1 action in rat skeletal muscle
Acitores, A., González, N., Sancho, V., Valverde, I., & Villanueva-Penacarrillo, M. (2004) · Journal of Endocrinology · doi:10.1677/joe.0.1800389 · Cited by 55
Broholm, C., Brandt, C., Schultz, N. S., Nielsen, A. R., Pedersen, B. K., & Schéele, C. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00586.2011 · Cited by 45
Self-citationKawano, Y., Rincón, J., Soler, A., Ryder, J. W., Nolte, L. A., Zierath, J. R., & Wallberg‐Henriksson, H. (1999) · Diabetologia · doi:10.1007/s001250051273 · Cited by 35
Arnes, L., González, N., Tornero-Esteban, P., Sancho, V., Acitores, A., Valverde, I., Delgado, E., & Villanueva-Peñacarrillo, M. (2008) · International Journal of Molecular Medicine · doi:10.3892/ijmm.22.1.127 · Cited by 33
Moreno, P., Nuche‐Berenguer, B., Gutiérrez-Rojas, I., Acitores, A., Sancho, V., Valverde, I., González, N., & Villanueva‐Peñacarrillo, M. L. (2011) · Journal of Molecular Endocrinology · doi:10.1530/jme-11-0127 · Cited by 27
Galante, P., Mosthaf, L., Kellerer, M., et al. (1995) · Diabetes · doi:10.2337/diabetes.44.6.646 · Cited by 21
Cited by
Short-chain fatty acids as potential regulators of skeletal muscle metabolism and function
Frampton, J., Murphy, K. G., Frost, G., & Chambers, E. S. (2020) · Nature Metabolism · doi:10.1038/s42255-020-0188-7 · Cited by 516
Pleiotropic Effects of GLP-1 and Analogs on Cell Signaling, Metabolism, and Function
Rowlands, J., Heng, J., Newsholme, P., & Carlessi, R. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00672 · Cited by 302
Effects of Glucagon-Like Peptide-1 on Oxidative Stress and Nrf2 Signaling
Oh, Y., & Jun, H.-S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms19010026 · Cited by 217
“In addition to its actions on the pancreas, GLP-1 reduces glucose production in the liver and increases glucose uptake in adipose tissue and muscle [64,78,79].”
BackgroundAmelioration of muscle wasting by glucagon‐like peptide‐1 receptor agonist in muscle atrophy
Hong, Y., Lee, J. H., Jeong, K. W., Choi, C. S., & Jun, H. (2019) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12434 · Cited by 188
Efficacy of increased resistant starch consumption in human type 2 diabetes
Bodinham, C. L., Smith, L., Thomas, E. L., Bell, J. D., Swann, J. R., Costabile, A., Russell-Jones, D. L., Umpleby, A. M., & Robertson, M. D. (2014) · Endocrine Connections · doi:10.1530/ec-14-0036 · Cited by 160
Metadata
- Authors
- Green, C. J., Henriksen, T. I., Pedersen, B. K., & Solomon, T. P. J.
- Affiliations
- University of Copenhagen (DK)
- Corresponding author
- Green, Charlotte J.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-08-28
- Volume
- 7
- Issue
- 8
- Pages
- e44284
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3429413
- OpenAlex
- W1984706454
- Cited by
- 80
- References
- 43
- Citations by year
- 2026: 5 · 2025: 10 · 2024: 7 · 2023: 3 · 2022: 3 · 2021: 4 · 2020: 3 · 2019: 7 · 2018: 8 · 2017: 5 · 2016: 5 · 2015: 8 · 2014: 3 · 2013: 7
- FWCI
- 2.31
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion, other-oa)
- Funders
- National Research Foundation
- European Foundation for the Study of Diabetes
- Danmarks Grundforskningsfond (# 02-512-55)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Keywords
- glucagon-like peptide-1, hyperglycemia, satellite cells, skeletal muscle fibers, glucose uptake, GLUT4, GLUT1, glycogen synthesis, PI3K signaling, insulin resistance, insulin signaling, GLP-1 receptor, glucose metabolism
- MeSH terms
- Glucagon-Like Peptide-1 Receptor, Cell Differentiation, Cells, Cultured, Glucose, Glycogen, Humans, Hyperglycemia, Insulin, Male, Signal Transduction, Receptors, Glucagon, Satellite Cells, Skeletal Muscle, Cell Proliferation, Glucagon-Like Peptide 1, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.